These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24844782)

  • 41. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
    Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China.
    Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB
    Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of cytomegalovirus retinitis with dihydroxypropoxymethylguanine in a patient with acquired immunodeficiency syndrome].
    Guelar A; Grau J; Buil JA; Castilla M
    Med Clin (Barc); 1987 Oct; 89(10):439-40. PubMed ID: 2824940
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.
    Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T
    Anticancer Res; 1996; 16(5A):2623-8. PubMed ID: 8917361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acyclovir and gancyclovir. Proprieties and current indications].
    Goetmann S; Decazes JM
    Pathol Biol (Paris); 1989 Nov; 37(9):1003-4. PubMed ID: 2691970
    [No Abstract]   [Full Text] [Related]  

  • 48. Herpes simplex virus drug-resistance: new mutations and insights.
    Andrei G; Snoeck R
    Curr Opin Infect Dis; 2013 Dec; 26(6):551-60. PubMed ID: 24152761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of Howell-Jolly body-like inclusions in ganciclovir toxicity using CellaVision DM96 analyser.
    Revol B; Thiebaut-Bertrand A; Carré M; Bulabois CE; Mossuz P; Mondet J
    Br J Haematol; 2016 Aug; 174(4):637-9. PubMed ID: 26456312
    [No Abstract]   [Full Text] [Related]  

  • 50. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes simplex virus resistance to acyclovir: clinical relevance.
    Pottage JC; Kessler HA
    Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
    J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postexposure prophylaxis of varicella in children with leukemia by oral acyclovir.
    Ishida Y; Tauchi H; Higaki A; Yokota-Outou Y; Kida K
    Pediatrics; 1996 Jan; 97(1):150-1. PubMed ID: 8545216
    [No Abstract]   [Full Text] [Related]  

  • 55. [The emergence of viruses resistant to antiviral agents: a new challenge].
    Boivin G
    Union Med Can; 1993; 122(1):31-6. PubMed ID: 8465473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
    Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
    J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient Howell-Jolly-body-like cytoplasmic inclusions in neutrophils after severe intoxication with alpha-lipoic acid.
    Schuff-Werner P; Pönisch W; Berg T; Kaiser T
    Scand J Clin Lab Invest; 2021 Feb; 81(1):8-11. PubMed ID: 33345642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Howell-Jolly body-like inclusions in neutrophils.
    Kahwash E; Gewirtz AS
    Arch Pathol Lab Med; 2003 Oct; 127(10):1389-90. PubMed ID: 14521445
    [No Abstract]   [Full Text] [Related]  

  • 59. Revisiting Howell-Jolly Body-Like Cytoplasmic Inclusions in Neutrophils: A Report of Two Cases and Confirmation of Nuclear Origin.
    Omman R; Kwong C; Shepherd D; Molnar JA; Velankar MM; Mirza KM
    J Hematol; 2017 Oct; 6(4):101-104. PubMed ID: 32300402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear tubulofilamentous inclusions in vipomas.
    Leclerc JP; Scotto JM
    Lancet; 1977 Mar; 1(8011):610. PubMed ID: 65704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.